Clinical trials
Phase 2 Inflammation trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Novo Nordisk A/S | 2 |
| AM-Pharma | 1 |
| Amgen | 1 |
| Bioxodes S.A. | 1 |
| Centocor, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| Jules Bordet Institute | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 11 |
| Crohn Disease | 5 |
| Arthritis, Rheumatoid | 2 |
| Stroke | 2 |
| Atherosclerosis | 1 |
| Bacterial Infections and Mycoses | 1 |
| Breast Neoplasms | 1 |
| Carotid Artery Diseases | 1 |
| Carotid Stenosis | 1 |
| Cerebral Hemorrhage | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.